Lisa Lindsay, PhD, MPH is a consultant epidemiologist at P95 Consulting. Dr. Lindsay earned her doctorate degree in Infectious Disease Epidemiology at the University of North Carolina, Chapel Hill, USA and her Master’s in Public Health degree in International Health and Epidemiology at Emory University in Atlanta, GA, USA.

She has also trained with the Vaccine Safety and Development branch at the Centers for Disease Control and Prevention. Her interests are in vaccine-preventable diseases and international health.

She has experience working in the fields of human papilloma virus (HPV), influenza, herpes simplex as 

well as safe vaccine delivery of mass immunizations and iodine deficiency. She has experience working on cohort studies, support of clinical trials including survey design, data linkage studies and meta-analyses. Dr. Lindsay has worked with international, national and community health organizations.


DRIVE: A call for tenders

Measuring brand-specific influenza vaccine effectiveness in EU/EEA: a call for tenders

Read more

New publication

P95 co-authored paper on Norovirus disease in Japan featured in PLoS Disease Forecasting & Surveillance ...
Read more

New publication

Paper of P95 co-authors has been published online

Read more